CN1115638A - External use medicine form - Google Patents
External use medicine form Download PDFInfo
- Publication number
- CN1115638A CN1115638A CN 94110715 CN94110715A CN1115638A CN 1115638 A CN1115638 A CN 1115638A CN 94110715 CN94110715 CN 94110715 CN 94110715 A CN94110715 A CN 94110715A CN 1115638 A CN1115638 A CN 1115638A
- Authority
- CN
- China
- Prior art keywords
- phase transformation
- medicament
- external
- substrate
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 64
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 239000000126 substance Substances 0.000 claims abstract description 4
- 238000010521 absorption reaction Methods 0.000 claims abstract description 3
- 230000009466 transformation Effects 0.000 claims description 45
- 239000000758 substrate Substances 0.000 claims description 23
- 230000000857 drug effect Effects 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 7
- 239000004744 fabric Substances 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 4
- 230000008018 melting Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000005060 rubber Substances 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000000704 physical effect Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 238000002360 preparation method Methods 0.000 abstract description 8
- 238000000554 physical therapy Methods 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 239000012188 paraffin wax Substances 0.000 abstract description 2
- 238000013160 medical therapy Methods 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000001993 wax Substances 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- -1 tincture Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000012782 phase change material Substances 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a preparation form of a medical external medicament, and aims to enhance the absorption capacity of human tissues to the medicament through a physical therapy effect, fully exert the medicament effect and facilitate the preparation and storage of the external medicament. The invention selects substances with phase change characteristics such as paraffin as drug matrix to prepare the phase change medicament together with the drug. The phase-change medicament integrates the physical therapy effect and the medical therapy effect into a whole, and the physical therapy effect and the medical therapy effect are synergistically acted on a human body, so that the treatment effect with half the effort can be achieved, and an effective treatment way is opened up for external treatment of internal diseases.
Description
A kind of dosage form of the relevant medical medicine for external use of the present invention.
The dosage form of medicine for external use has water preparation, unguentum, tincture, powder, oil preparation etc. at present, and the substrate of used medicine is water, ethanol, vaseline, vegetable oil, glycerol, starch etc., and there is following problem in the medicine for external use of these dosage forms:
1. the common feature of the medicine for external use of above-mentioned dosage form is the restriction of depositing Shi Shouqi encapsulation, and after encapsulation was opened, drug effect was persistence and scatters and disappears and weaken.
2. skin is limited to the absorbability of above-mentioned dosage form external used medicine under general state, makes the drug effect performance be subjected to certain restriction.
3. some Chinese herbal medicine for external use preparations are difficult to deposit the popularization and application that has limited it because of its water decoction.
The purpose of this invention is to provide a kind of medicine for external use novel form that can remedy above-mentioned external-use drug form weak point, strengthen the absorbability of skin by the physical therapy effect to medicine, reach the purpose that physical therapy and medication organically combine, for inner disease outer treat is opened up a kind of dynamical Therapeutic Method.
The present invention is achieved in that topical agent is made up of medicine and substrate, it is characterized in that used substrate is to have the phase transformation substrate that the material of phase-change characteristic constitutes, and makes the phase transformation medicament with medicine with phase transformation substrate.Can make the fusing of phase transformation medicament by heating, discharge contained drug effect and bring into play the therapeutical effect of medicine, simultaneously, phase transformation substrate can produce persistent warm-heat effect, makes the skin histology telangiectasis, body of gland is open, local sweating promotes and has strengthened the absorbability of skin to medicine, and local organization blood circulation under warm-heat effect is accelerated, thereby promoted the performance of the efficacy of a drug, made phase transformation substrate and medicine produce collaborative mutually therapeutic effect.Drug effect is closed closely, makes the phase transformation medicament when non-working condition, be easy to deposit and preserve drug effect.
The selected phase transformation substrate of the present invention is the organic high molecular compound nontoxic, harmless, non-stimulated to human body, and as wax class, esters, polymerization alcohols, TPO and composition thereof, its melting range is 40-70 ℃, and best melting range is 50-6 ℃.Fusing point is lower than 40 ℃ phase transformation substrate easy fusing in summer and difficult the preservation, and heat effect is poor, and therapeutic effect is also poor; Fusing point is higher than 70 ℃, then surpasses the treatment temperature of human body tolerance and can't use.Can add inorganic substances in the phase transformation substrate of the present invention, as white carbon, active hargil etc. to improve the mechanical and physical performance of phase transformation substrate.
The used medicine of the present invention is chemical drugs, Chinese herbal medicine and various biological preparation etc., according to the characteristic and the needs of used medicine in the specific prescription, pharmaceutical preparation directly added in the phase transformation substrate mix or take effective ingredient and make the phase transformation medicament with upright the connecing of phase transformation base.
Phase transformation medicament of the present invention can be taked following manner to execute to control:
1. adopt flexible material absorption or adhere to the phase transformation medicament, make the phase transformation tablet, heating makes its fusing and spreads on affected part constant temperature treatment to the phase transformation tablet to adopt constant temperature heating device during use.Flexible material can be selected fabric, adhesive-bonded fabric, paper, sponge etc. for use.
2. the phase transformation medicament is filled in the soft sealing bag, make the phase transformation medicated bag, the material that its soft sealing bag selects for use the phase transformation medicament that can make fusing quantitatively to appear the bag surface is made, as rubber, rubber and plastic and composite etc., pattern of fever or outer pattern of fever in this medicated bag can be made into, make the fusing of phase transformation medicament and quantitatively ooze out the medicated bag surface by inside heating or external heat during use, spread on the affected part treatment.
The present invention adopts phase change material to have the following advantages and effect as drug matrices.
1. naturopathy and Drug therapy are organically combined, under the persistent warm-heat effect of phase transformation substrate, skin histology blood capillary and sweat gland expansion, blood circulation is accelerated, thereby skin histology is strengthened the absorbability of medicine, and the efficacy of a drug is effectively brought into play, and resonable curative effect should be worked in coordination with down with the mutual of medication effect, can obtain the curative effect of getting twice the result with half the effort, this phase transformation medicament is that inner disease outer treat has been opened up a kind of new dynamical Therapeutic Method.
2. phase transformation substrate has good closed performance, can preserve drug effect effectively when curdled appearance, then can bring into play drug effect effectively by heat fused during use, has the advantages that to be easy to deposit.
3. preparation such as Chinese herbal medicine can be directly fried in phase transformation substrate, so this phase transformation medicament provides a kind of simple and practical method for the preparation and the storage of Chinese herbal medicine for external use.
Be specific embodiments of the invention below:
Select 54-58 ℃ medical pure wax and specific medicine prescription for use, with White paraffin water proof heat fused, the medicine that need are fried is put into wax, continue fried with 70 ℃ wax temperature, the time fried according to needing to be grasped of the property of medicine, filter then, put into other ground medicated powder mix homogeneously again, be prepared into phase transformation medicine wax.
1. the making of phase transformation tablet and use:
Select 40-80g/M for use
2Non-woven fabrics, immerse in the medicine wax of fusing, make tablet through mangle-cooling-operations such as section.During use the phase transformation tablet being spread on the affected part continues heating with 58-60 ℃ thermostatic heater to tablet and executes and control.
2. the making of phase transformation medicated bag and use:
Select for use self to possess heater, and the compounded rubber bag that the medicine wax of fusing is quantitatively oozed out, will pour in the bag after the fusing of medicine wax, the phase transformation medicated bag is made in encapsulation, controls by executing after the fusing of medicated bag self heating messenger drug wax.
Claims (5)
1. external-use drug form, form by medicine and substrate, it is characterized in that used substrate is the phase transformation substrate with material formation of phase-change characteristic, medicine is made external phase transformation medicament with phase transformation substrate, phase transformation substrate is solid under the room temperature, drug effect can be sealed, then drug effect can be discharged when being heated to molten state.
2. external-use drug form according to claim 1 is characterized in that phase transformation substrate is organic high molecular compound, and as wax class, esters, polymerization alcohols, TPO and composition thereof, melting range is 40-70 ℃, and best melting range is 50-60 ℃.
3. according to claim 1 and the described external-use drug form of claim 2, it is characterized in that to add inorganic substances in the said phase transformation substrate, as white carbon, active hargil etc., to improve the mechanical and physical property of phase transformation substrate.
4. external-use drug form according to claim 1 is characterized in that said phase transformation medicament can or adhere to flexible material absorption, as fabric, adhesive-bonded fabric, paper, sponge material etc., makes external phase transformation tablet, controls by tablet is heated to execute.
5. external-use drug form according to claim 1, it is characterized in that said phase transformation medicament can be filled in the soft sealing bag that the phase transformation medicament that can make fusing quantitatively appears, as rubber bag etc., make the phase transformation medicated bag, control by the fusing of phase transformation medicament being executed medicated bag inside or external heat.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94110715 CN1115638A (en) | 1994-07-25 | 1994-07-25 | External use medicine form |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94110715 CN1115638A (en) | 1994-07-25 | 1994-07-25 | External use medicine form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1115638A true CN1115638A (en) | 1996-01-31 |
Family
ID=5034652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94110715 Pending CN1115638A (en) | 1994-07-25 | 1994-07-25 | External use medicine form |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1115638A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100397866C (en) * | 2001-12-06 | 2008-06-25 | 佳能株式会社 | Image processing apparatus, image processing method, and program |
| WO2011079746A1 (en) * | 2009-12-30 | 2011-07-07 | 华东医学生物技术研究所 | Tube comprising fusible layer |
-
1994
- 1994-07-25 CN CN 94110715 patent/CN1115638A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100397866C (en) * | 2001-12-06 | 2008-06-25 | 佳能株式会社 | Image processing apparatus, image processing method, and program |
| WO2011079746A1 (en) * | 2009-12-30 | 2011-07-07 | 华东医学生物技术研究所 | Tube comprising fusible layer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0791397B2 (en) | Flexible hydrophilic gel film, and method of making and using the same | |
| CN101085300A (en) | Plaster for treating hyperosteogeny and pain, and its preparation method | |
| CN109674862A (en) | A kind of cold compress dressing and preparation method thereof and the dressing patch containing the cold compress dressing | |
| CN106726101B (en) | A kind of wax therapy Chinese medicine wax stone and preparation method thereof | |
| CN106474444A (en) | A kind of external application Chinese medicine medicated bag formula, medicated bag and its using method | |
| CN1115638A (en) | External use medicine form | |
| CN1277566C (en) | Method for preparing medicine for treatment of arthralgia-syndrome pain disease | |
| CN1086953C (en) | Medical oil for treating burn and scald and its preparing process | |
| KR20050116503A (en) | Raw herbal extracts composition and cataplasa | |
| CN1432378A (en) | Medicine for treating burns and scalds and its prepn process | |
| CN108704017A (en) | A kind of pharmaceutical composition and its preparation method and application removed necrosis and promoted granulation | |
| JPH02119863A (en) | Heating moxa cautery and method thereof | |
| CN111905023A (en) | Cold and hot medicinal moxibustion with effects of relieving fatigue, reducing fine lines and protecting eyes and preparation method thereof | |
| CN1116048C (en) | External-use extract for treating burns and scalds fast and its preparation | |
| CN1806823B (en) | Externally applied wind-expelling Chinese medicinal composition plaster | |
| CN108853243A (en) | Treat psoriasic xanthate cream itself and preparation method | |
| CN107648356A (en) | A kind of Chinese medicine combination formulations for treating burn and scald | |
| CN1390599A (en) | Prescription of lotion for treating pile and fistula and its preapring process | |
| CN100462098C (en) | Chinese medicine ointment for treating bone disease and its preparing method | |
| CN105213677A (en) | A kind of Chinese medicinal film for topical anesthesia and preparation method thereof | |
| CN109432299A (en) | A kind of bamboo rat oil wound cream and preparation method thereof | |
| CN1034137A (en) | A kind of preparation method of warm application compress | |
| CN1263486C (en) | Ointment for treating burn and scald and its preparation method | |
| CN1063407A (en) | A kind of manufacture method of Chinese medicine fomentation bag for stop pain | |
| CN1706471A (en) | Huoluo plaster and its manufacturing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |